Ultragenyx Pharmaceutical Inc. employs approximately 1,371 people worldwide. As a biopharmaceutical enterprise focused heavily on the discovery, development, and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, the company maintains specialized research laboratories, clinical development teams, and regulatory compliance units dedicated to bringing life-changing treatments to patients with high unmet medical needs.

Iowa Falls State Bank carries a deep historical lineage tracing back to 1882 with the founding of the Commercial Bank of Iowa Falls, which later transitioned into a national charter. Following the unprecedented nationwide bank closures of the Great Depression, the institution was formally reorganized and opened its doors under its current name on May 25, 1933. For over 90 years under its modern charter—and spanning more than 140 years of combined local banking heritage—the institution has served as a cornerstone of financial stability in Iowa, expanding its physical and drive-up infrastructure while maintaining a steadfast commitment to high-touch customer service and local economic growth.